Our recent analysis titled "Angioplasty Balloons Market Forecast to 2030 - Global Analysis - Type, Application, End User, and Geography" indicates that the market was valued at approximately US$ 2.71 billion in 2022 and is projected to grow to US$ 3.60 billion by 2030, reflecting an estimated compound annual growth rate (CAGR) of 3.6% from 2022 to 2030.

Angioplasty is a medical procedure aimed at widening narrowed or blocked coronary arteries to restore adequate blood flow. The healthcare landscape is evolving towards value-based care, which emphasizes cost-effectiveness and improved patient outcomes. The angioplasty balloon market will be shaped by the ability of these devices to enhance patient results, decrease revascularization rates, and offer lower costs compared to alternative treatments. Angioplasty balloons present a less invasive option for treating obstructed arteries when compared to traditional surgical techniques.

The HEARTS initiative in the Americas, spearheaded by the Ministries of Health in collaboration with local stakeholders and the technical support of the Pan American Health Organization (PAHO), is currently being implemented in over 1,400 health facilities across 22 countries in the region. By 2025, HEARTS aims to establish a model for managing cardiovascular risk factors, including hypertension, diabetes, and dyslipidemia, within primary healthcare systems throughout the Americas.

In Europe, public healthcare expenditure has been increasing at a rate that surpasses domestic spending, particularly in wealthier nations. Initiatives such as the European Commission's EU4Health program, the Next Generation Recovery Funds, and Horizon Europe Research Funds present significant opportunities to tackle the challenges posed by cardiovascular diseases. These programs aim to enhance the cardiovascular health of the population through the implementation of preventive strategies outlined in an EU Action Plan for improved cardiovascular health. This comprehensive plan addresses the entire patient journey, from prevention and early detection to treatment access and quality of life, while also recognizing the crucial role of digital innovation at every stage. Consequently, the rise in healthcare spending and government initiatives focused on heart health are expected to create favorable conditions for growth in the angioplasty balloons market.

**Market Insights by Type**
The angioplasty balloons market is categorized by type into normal balloons, drug-eluting balloons, cutting balloons, and scoring balloons. In 2022, the normal balloons segment dominated the market share. However, the drug-eluting balloons segment is projected to experience the highest CAGR from 2022 to 2030. Drug-coated balloons (DCB), particularly those coated with paclitaxel, are increasingly utilized in endovascular therapy to enhance the patency rates of angioplasty procedures. When addressing complications related to hemodialysis access, drug-eluting balloons may, in the short term, necessitate fewer reinterventions and associated healthcare costs compared to standard balloon angioplasty.

**Market Insights by End User**
The angioplasty balloons market is also segmented by end user, which includes hospitals, ambulatory surgery centers, and other facilities. The hospitals segment accounted for the largest share of the market in 2022 and is expected to achieve the highest CAGR during the forecast period from 2022 to 2030. This growth is attributed to shorter hospital stays and the availability of advanced medical services. Additionally, procedures conducted in ambulatory surgery centers are often more cost-effective, contributing to a reduction in overall medical expenses. These factors are driving the expansion of the ambulatory surgery center segment.

In preparing the report on the angioplasty balloons market, several key secondary sources were consulted, including the European Society of World Heart Federation and the World Health Organization.